CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates

Abstract : Controlling graft-versus-host disease (GVHD) remains a major unmet need in stem cell transplantation, and new, targeted therapies are being actively developed. CD28-CD80/86 costimulation blockade represents a promising strategy, but targeting CD80/CD86 with CTLA4-Ig may be associated with undesired blockade of coinhibitory pathways. In contrast, targeted blockade of CD28 exclusively inhibits T cell costimulation and may more potently prevent GVHD. Here, we investigated FR104, an antagonistic CD28-specific pegylated-Fab′, in the nonhuman primate (NHP) GVHD model and completed a multiparameter interrogation comparing it with CTLA4-Ig, with and without sirolimus, including clinical, histopathologic, flow cytometric, and transcriptomic analyses. We document that FR104 monoprophylaxis and combined prophylaxis with FR104/sirolimus led to enhanced control of effector T cell proliferation and activation compared with the use of CTLA4-Ig or CTLA4-Ig/sirolimus. Importantly, FR104/sirolimus did not lead to a beneficial impact on Treg reconstitution or homeostasis, consistent with control of conventional T cell activation and IL-2 production needed to support Tregs. While FR104/sirolimus had a salutary effect on GVHD-free survival, overall survival was not improved, due to death in the absence of GVHD in several FR104/ sirolimus recipients in the setting of sepsis and a paralyzed INF-γ response. These results therefore suggest that effectively deploying CD28 in the clinic will require close scrutiny of both the benefits and risks of extensively abrogating conventional T cell activation after transplant.
Document type :
Journal articles
Complete list of metadatas

Cited literature [88 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02157599
Contributor : Ana Paula Dutra Azevedo <>
Submitted on : Monday, June 17, 2019 - 10:33:11 AM
Last modification on : Wednesday, August 7, 2019 - 3:34:13 PM

File

jci-128-98793.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Benjamin Watkins, Victor Tkachev, Scott Furlan, Daniel Hunt, Kayla Betz, et al.. CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates. Journal of Clinical Investigation, American Society for Clinical Investigation, 2018, 128 (9), pp.3991-4007. ⟨10.1172/JCI98793⟩. ⟨inserm-02157599⟩

Share

Metrics

Record views

58

Files downloads

110